Relation between serum insulinlike growth factor-1, insulinlike growth factor binding protein-2, and insulinlike growth factor binding protein-3 and nutritional intake in premature infants with bronchopulmonary dysplasia

Journal of Pediatric Gastroenterology and Nutrition

Volumn 32, Issue 5, 2001, Pages 542-549

  Price, Wayne A ^a   Lee, Edward ^a   Maynor, Angela ^a   Stiles, Alan D ^a   Clemmons, David R ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Bronchopulmonary dysplasia; Growth; IGF 1; IGFBP 2; IGFBP 3; Nutrition; Premature infant

Indexed keywords

PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY WEIGHT; CALORIC INTAKE; CALORIE; CHILD GROWTH; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; GESTATIONAL AGE; HUMAN; INFANT; INFANT FEEDING; LUNG DYSPLASIA; LUNG INJURY; MAJOR CLINICAL STUDY; MEASUREMENT; NEWBORN; NUTRITIONAL STATUS; PREMATURITY; PRIORITY JOURNAL; PROTEIN INTAKE; WEIGHT GAIN;

BIOLOGICAL MARKERS; BRONCHOPULMONARY DYSPLASIA; CASE-CONTROL STUDIES; COHORT STUDIES; DIETARY PROTEINS; ENERGY INTAKE; HUMANS; INFANT NUTRITION PHYSIOLOGY; INFANT, NEWBORN; INFANT, PREMATURE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; NUTRITIONAL STATUS; RADIOIMMUNOASSAY; REGRESSION ANALYSIS; WEIGHT GAIN;

EID: 0034961452     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-200105000-00010     Document Type: Article

References (25)

1. Evaluation of criteria for chronic lung disease in surviving very low birth weight infants. Newborn Lung Project
2. Nutrition in neonatal chronic lung disease
3. Rapid turnover transport proteins, plasma albumin, and growth in low birth weight infants
4. Prealbumin as a biochemical marker of nutritional adequacy in premature infants
5. Proteins used in nutritional assessment
6. Use of plasma somatomedin-C/insulin-like growth factor I measurements to monitor the response to nutritional repletion in malnourished patients
7. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-1) and IGF-binding proteins in children and adults
8. Reduction of plasma immunoreactive somatomedin C during fasting in humans
9. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins
10. Use of insulin-like growth factor I (IGF-I) and IGF-binding protein measurements to monitor feeding of premature infants
11. Breast-feeding and growth factors in preterm newborn infants
12. Serum insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) in growing preterm infants on enteral nutrition
13. Intrauterine growth as estimated from live-born birth weight data at 24 to 42 weeks of gestation
14. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay
15. Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects
16. Use of insulin-like growth factor-binding protein-2 (IGFBP- 2), IGFBP-3, and IGF-1 for assessing growth hormone status in short children
17. Growth and growth factors in premature infants receiving dexamethasone for bronchopulmonary dysplasia
18. Nutritional regulation of IGF-1 and IGFBPs
19. Protein intake and energy requirements of the infant
20. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: A basis for programming by undernutrition
21. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth
22. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
23. The evolution of changes in immunoreactive serum insulin-like growth factors (IGFs), IGF-binding proteins, circulating growth hormone (GH), and GH-binding protein as a result of short-term dexamethasone treatment
24. Glucocorticoids effect on somatomedins and somatomedin inhibitors